PROVEN PERFORMANCE ACROSS THREE PIVOTAL STUDIES
The PRECISE and PRECISE II trials investigated the system’s accuracy, longevity and safety, along with glycemic control data and self-reported quality of life. The PRECISION study captured additional data on safety and accuracy. Combined, the three studies supported the clinical efficacy of Eversense and its exceptional long-term accuracy and wear time.
The advanced sensor technology and under-the-skin placement help patients reach unprecedented levels of wear time, leading to improved clinical outcomes.